BRCA1/2 in high-risk African American women with breast cancer: Providing genetic testing through various recruitment strategies

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 401-407

  Pal, Tuya ^a,b   Vadaparampil, Susan ^a,b   Betts, Judy ^a   Miree, Cheryl ^a   Li, Song ^c   Narod, Steven A ^c  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

AFRICAN AMERICAN; ARTICLE; BREAST CANCER; EXON; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MUTATION RATE; ONSET AGE;

AFRICAN AMERICANS; BREAST NEOPLASMS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC SCREENING; HETEROZYGOTE; HUMANS; RISK FACTORS;

EID: 50649124879     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0108     Document Type: Article

References (64)

1. Adams-Campbell LL, Makambi KH, Palmer JR, Rosenberg L (2007) Diagnostic accuracy of the Gail model in the black women's health study. Breast J 13:332-336.
2. Aitken J, Bain C, Ward M, et al. (1995) How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141:863-871.
3. American Cancer Society (2005) Cancer Facts & Figures 2005. American Cancer Society, Inc., Atlanta.
4. Armstrong K, Micco E, Carney A, et al. (2005) Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. JAMA 293:1729-1736.
5. Aziz H, Hussain F, Sohn C, et al. (1999) Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22:436-440.
6. Bauer KR, Brown M, Cress RD, et al. (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer registry. Cancer 109:1721-1728.
7. BIC (Breast Cancer Information Core). Website: http://www.nhgri.nih.gov/ Intramural_research/Lab_transfer/BIC/. Accessed 7/19/2007.
8. Bondy ML, Newman LA (2003) Breast cancer risk assessment models: applicability to African-American women. Cancer 97:230-235.
9. Breast Cancer Linkage Consortium (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505-1510.
10. Carey LA, Perou CM, Livasy CA, et al. (2006) Race, breast cancer subtypes, and survival in the Carolina breast cancer study. JAMA 295:2492-2502.
11. Claus EB, Risch NJ, Thompson WD (1990) Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 131:961-972.
12. Claus EB, Schildkraut J, Iversen ES, et al. (1998) Effect of BRCA1 and BRCA2 on the association between breast cancer risk and family history. J Natl Cancer Inst 90:1824-1829.
13. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324.
14. Couch FJ, DeShano ML, Blackwood MA, et al. (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336:1409-1415.
15. Couch FJ, Weber BL (1996) Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core. Hum Mutat 8:8-18.
16. Curry L, Jackson J (2003) The science of including older ethnic and racial group participants in health-related research. Gerontologist 43:15-17.
17. Easton DF, Ford D, Bishop DT (1995) Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 56:265-271.
18. Fackenthal JD, Sveen L, Gao Q, et al. (2005) Complete allelic analysis of BRCA1 and BRCA2 variants in young Nigerian breast cancer patients. J Med Genet 42:276-281.
19. Frank TS, Deffenbaugh AM, Reid JE, et al. (2002) Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals. J Clin Oncol 20:1480-1490.
20. Futreal PA, Liu Q, Shattuck-Eidens D, et al. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science 266:120-122.
21. Gail MH, Brinton LA, Byar DP, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886.
22. Gao Q, Adebamowo CA, Fackenthal J, et al. (2000a) Protein truncating BRCA1 and BRCA2 mutations in African women with pre-menopausal breast cancer. Hum Genet 107:192-194.
23. Gao Q, Neuhausen S, Cummings S, et al. (1997) Recurrent germ-line BRCA1 mutations in extended African American families with early-onset breast cancer. Am J Hum Genet 60:1233-1236.
24. Gao Q, Tomlinson G, Das S, et al. (2000b) Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer. Hum Genet 107:186-191.
25. Grann VR, Jacobson JS, Troxel AB, et al. (2005) Barriers to minority participation in breast carcinoma prevention trials. Cancer 104:374-379.
26. Haffty BG, Harrold E, Khan AJ, et al. (2002) Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status. Lancet 359:1471-1477.
27. Haffty BG, Silber A, Matloff E, et al. (2006) Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women. J Med Genet 43:133-137.
28. Halbert CH, Brewster K, Collier A, et al. (2005) Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol 23:7967-7973.
29. James AS, Hudson MA, Campbell MK (2003) Demographic and psychosocial correlates of physical activity among African Americans. Am J Health Behav 27:421-431.
30. James CR, Quinn JE, Mullan PB, et al. (2007) BRCA1, a potential predictive biomarker in the treatment of breast cancer. Oncologist 12:142-150.
31. John EM, Miron A, Gong G, et al. (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869-2876.
32. Kanaan Y, Kpenu E, Utley K, et al. (2003) Inherited BRCA2 mutations in African Americans with breast and/or ovarian cancer: a study of familial and early onset cases. Hum Genet 113:452-460.
33. Kinney AY, Simonsen SE, Baty BJ, et al. (2006) Acceptance of genetic testing for hereditary breast ovarian cancer among study enrollees from an African American kindred. Am J Med Genet A 140:813-826.
34. Love RR, Evans AM, Josten DM (1985) The accuracy of patient reports of a family history of cancer. J Chronic Dis 38:289-293.
35. Malone KE, Daling JR, Doody DR, et al. (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297-8308.
36. Marcus JN, Watson P, Page DL, et al. (1996) Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709.
37. Marcus JN, Watson P, Page DL, et al. (1997) BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44:275-277.
38. Mefford HC, Baumbach L, Panguluri RC, et al. (1999) Evidence for a BRCA1 founder mutation in families of West African ancestry. Am J Hum Genet 65:575-578.
39. Millon-Underwood S, Sanders E, Davis M (1993) Determinants of participation in state-of-the-art cancer prevention, early detection/screening, and treatment trials among African-Americans. Cancer Nurs 16:25-33.
40. Moller P, Borg A, Evans DG, et al. (2002) Survival in prospectively ascertained familial breast cancer: analysis of a series stratified by tumour characteristics, BRCA mutations and oophorectomy. Int J Cancer 101:555-559.
41. Moorman PG, Newman B, Millikan RC, et al. (1999) Participation rates in a case-control study: the impact of age, race, and race of interviewer. Ann Epidemiol 9:188-195.
42. Myriad Genetics, Laboratories and Pharmaceuticals. Website: http://www.myriadtests.com/provider/brca-mutation-prevalence.htm. Accessed 11/7/2007.
43. Nanda R, Schumm LP, Cummings S, et al. (2005) Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry. JAMA 294:1925-1933.
44. Newman LA (2005) Breast cancer in African-American women. Oncologist 10:1-14.
45. Newman B, Mu H, Butler LM, et al. (1998) Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA 279:915-921.
46. Novakovic B, Goldstein AM, Tucker MA (1996) Validation of family history of cancer in deceased family members. J Natl Cancer Inst 88:1492-1493.
47. Olopade OI, Fackenthal JD, Dunston G, et al. (2003) Breast cancer genetics in African Americans. Cancer 97:236-245.
48. Pal T, Permuth-Wey J, Holtje T, Sutphen R (2004) BRCA1 and BRCA2 mutations in a study of African American breast cancer patients. Cancer Epidemiol Biomarkers Prev 13:1794-1799.
49. Panguluri RC, Brody LC, Modali R, et al. (1999) BRCA1 mutations in African Americans. Hum Genet 105:28-31.
50. Parmigiani G, Berry D, Aguilar O (1998) Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 62:145-158.
51. Parmigiani G, Chen S, Iversen ES, Jr., et al. (2007) Validity of models for predicting BRCA1 and BRCA2 mutations. Ann Intern Med 147:441-450.
52. Pegoraro RJ, Moodley M, Rom L, et al. (2003) P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans. Int J Gynecol Cancer 13:444-449.
53. Reiner AP, Carlson CS, Ziv E, et al. (2007) Genetic ancestry, population sub-structure, and cardiovascular disease-related traits among African-American participants in the CARDIA study. Hum Genet 121:565-575.
54. Rimer BK, Conaway MR, Lyna PR, et al. (1996) Cancer screening practices among women in a community health center population. Am J Prev Med 12:351-357.
55. Royal C, Baffoe-Bonnie A, Kittles R, et al. (2000) Recruitment experience in the first phase of the African American Hereditary Prostate Cancer (AAHPC) study. Ann Epidemiol 10:S68-S77.
56. Satia JA, Galanko JA, Rimer BK (2005) Methods and strategies to recruit African Americans into cancer prevention surveillance studies. Cancer Epidemiol Biomarkers Prev 14:718-721.
57. Shattuck-Eidens D, McClure M, Simard J, et al. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications for presymptomatic testing and screening. JAMA 273:535-541.
58. Shen D, Wu Y, Subbarao M, et al. (2000) Mutation analysis of BRCA1 gene in African-American patients with breast cancer. J Natl Med Assoc 92:29-35.
59. Susswein LR, Skrzynia C, Lange LA, et al. (2008) Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer. J Clin Oncol 26:32-36.
60. Thompson HS, Valdimarsdottir HB, Duteau-Buck C, et al. (2002) Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women. Cancer Epidemiol Biomarkers Prev 11:1579-1585.
61. Verhoog LC, Brekelmans CT, Seynaeve C, et al. (1998) Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351:316-321.
62. Veronesi A, de Giacomi C, Magri MD, et al. (2005) Familial breast cancer: characteristics and outcome of BRCA 1-2 positive and negative cases. BMC Cancer 5:70-75.
63. Vollmer WM, Svetkey LP, Appel LJ, et al. (1998) Recruitment and retention of minority participants in the DASH controlled feeding trial. DASH Collaborative Research Group. Dietary approaches to stop hypertension. Ethn Dis 8:198-208.
64. Wagner TM, Hirtenlehner K, Shen P, et al. (1999) Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet 8:413-423.